Back to Newsroom

Auris Medical to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 10, 2017

Zug, Switzerland, August 3, 2017 – Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that it will report its financial results for the second quarter of 2017 on Thursday, August 10, 2017.